Pneumology departement, Pitié-Salpêtrière hospital, GHU APHP-Sorbonne Université
Paris, 75013, France
NCT Number: NCT05498883
This study aims to measure the quality of life of ALS patients by the SRI questionnaire, in two distinct patient groups : Patient requiring initiation of NIV, and patients 24 hours dependent on NIV
This study also seeks to assess the quality of life of the caregivers with the Zarit Burden interview in those two populations
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75013, France
The course of the study is as follows:
Patient newly ventilated with NIV :
inclusion is done on the day of starting NIV. On the day of inclusion: Clinical examination, completion of the ALS-FRS score, completion of the SRI score.
For the caregiver: Completion of the Zarit Burden Inerview Reassessment of scores (SRI, Zarit-burden, ALS-FRS), at three-month and six-month follow-up
Patient dependent of NIV :
On the day of inclusion: Clinical examination, completion of the ALS-FRS score, completion of the SRI score.
For the caregiver: Completion of the Zarit Burden Inerview Reassessment of scores (SRI, Zarit-burden, ALS-FRS), at three-month follow-up
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients :
Caregivers :
Exclusion criteria
Patients :
Caregivers :
completion of the SRI score
Time frame: six months
SRI questionnaire assessment at initiation of NIV, at 3-month follow-up and at 6-month follow-up
Time frame: three months
SRI questionnaire assessment at inclusion and at 3-month follow-up
Time frame: Six months
Zarit Burden interview questionnaire in ALS patient caregiver, in both groups (initiation of NIV and NIV-dependent patients) at inclusion, 3-month follow-up (both groups) and at 6-month follow-up (in group 1)
Assistance Publique - Hôpitaux de Paris
Other
Acronym: Quality EvALS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01925196
Amyotrophic Lateral Sclerosis, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05562960
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT04259255
ALS, Amyotrophic Lateral Sclerosis
Phoenix, Arizona, United States
View Trial DetailsNCT05189106
Alzheimer Disease, Amyotrophic Lateral Sclerosis
Boston, Massachusetts, United States
View Trial Details